Abnormal endometrium thickness and infertility

AN EXPLORATORY STUDY TO EVALUATE THE KSHETRA VISHODHANA EFFECT OF ROUPYADI BHASMA IN FEMALE INFERTILITY W.S.R. TO ENDOMETRIAL THICKNESS

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/01/011601

Enrollment

Registered

2018-01-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- infertile,abnormal endometrial thickness

Interventions

Intervention1: roupyadi bhasma: 202.5mg BD for 3 days i.e. 5th, 6th and 7th day of the menstrual cycle, with honey, administered orally, for one menstrual cycle Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group 20- 40 years. 2. Clinically diagnosed cases of: i. Primary/ secondary infertility. ii. Regular/ irregular menstrual history. 3. Sonologically diagnosed cases of: i. Endometrial thickness > 11mm. ii. Endometrial thickness

Exclusion criteria

Exclusion criteria: 1. Endocrinal disorders. 2. Venereal diseases. 3. Any other conditions of the endometrium causing infertility.

Design outcomes

Primary

Measure	Time frame
ï?§ Roupyadi bhasma might be effective in making the endometrium receptive by normalizing the endometrial thickness.Timepoint: 5 days after intervention	—

Secondary

Measure	Time frame
fertility rateTimepoint: 1 month	—

Countries

India

Contacts

Public ContactDr Swarda Uppin

KAHER Shri BM Kankanawadi Mahavidyalaya, PG Studies and Research Centre, Shahpur, Belagavi

vaidyasukumar@gmail.com9986125625

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026